What should I know about the Rotavir vaccine?
One of the first vaccines that doctors recommend for infants is the Rotavirus. Rotavirus is the most common cause of severe diarrhea in infants and children and almost all children will be infected at the age of five. However, the dehydration and imbalance of electrolytes caused by rotavirus may be the most problematic in very young and it is recommended that the rotavirus vaccine is given from six to twelve weeks of age. Two more doses are then administered at intervals for approximately eight weeks. The rotavirus vaccine should not be served six weeks ago or after the age of 32 weeks. The stunning difference in deaths is largely caused by unhygienic conditions, lack of available routine medical care and modest sources for the treatment of dehydration in undeveloped countries. It is assumed that at least two rotavirus periods - where the virus is most often closed in cold weather - although experts note that the efficiency of the vaccine is lower during the second season than during the first. After jAll three doses are estimated, the efficacy of a rotavirus vaccine is estimated to be 74% against any rotavirus infection and 98% against severe infection.
The first vaccine against Rotavir, Rotashield, was licensed in August 1998, but was withdrawn next year due to a connection between vaccine and intususception or an obstacle to the intestine in infants who received the vaccine. Rotateq was later licensed in 2006, and although Intususception reports do not exceed the expected amount of CDC, this Rotaviro vaccine is also indicated by a warning to be vigilant for intestinal obstruction. No data security for this vaccine is available for infants with a weakened immune system or with a history of gastrointestinal disorders.
The more common side effects of the Rotavirus vaccine include diarrhea and vomiting, which affects up to 24% of vaccinated infants. It was also found that the virus shed up to 8.9% of vaccinated infants andChildren and can continue to shed up to fifteen days. Since Rotavirus enters the body through the mouth and spreads through faecal oral contact, caregivers should be particularly hard to wash their hands when they take care of a child who has received a rotavirus vaccine to prevent the spread of rotavirus to others.
It can be argued that Rotaviru vaccine often causes the actual effect against infants. In fact, infants under three months are rarely infected with rotavirus due to passive parent antibodies and, if applicable, antibodies received through breast milk. These infants will be nonethelss exposed to a living rotavir during this time of natural immunity if the vaccine is planned. In addition, the child is likely to experience a rotavirus infection later as soon as the vaccine efficiency disappears. After the first rotavirus infection, 88% of children become immune to serious symptoms and immunity is strengthened only with everyone (usually without symptoms) subsequent inFeka.
Merck vaccine statements may arise that "Rotateq has not been evaluated on carcinogenic or mutagenic potential or its potential to disrupt fertility". Merck also states that "Relationship between Rotateq's Answers against Rotavirus Gastroenteritis has not been set." In other words, they did not show the relationship between their vaccine and immunity to the virus.
Rotavirus is treated with rest, liquids and a bland diet until the child stops vomiting. In severe cases, it may be necessary to prevent dehydration. Since this virus is rarely fatal in developed countries and can prevent them from being washed properly, parents and caregivers can pause to consider the risks over the advantages of the Rotavir vaccine before they agree. As with any vaccine, the risk of side effects may be reduced by deciding to serve separately from any other vaccine.